Eli Lilly and Co (LLY)
298.85
+12.58 (+4.39%)
USD |
NYSE |
May 20, 16:00
299.80
+0.95 (+0.32%)
After-Hours: 20:00
Eli Lilly Gross Profit Margin (Quarterly): 73.47% for March 31, 2022
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2022 | 73.47% |
| December 31, 2021 | 74.37% |
| September 30, 2021 | 78.87% |
| June 30, 2021 | 71.02% |
| March 31, 2021 | 72.40% |
| December 31, 2020 | 76.88% |
| September 30, 2020 | 76.89% |
| June 30, 2020 | 77.78% |
| March 31, 2020 | 79.26% |
| December 31, 2019 | 79.02% |
| September 30, 2019 | 78.55% |
| June 30, 2019 | 80.04% |
| March 31, 2019 | 77.64% |
| December 31, 2018 | 79.96% |
| September 30, 2018 | 78.28% |
| June 30, 2018 | 77.90% |
| March 31, 2018 | 76.54% |
| December 31, 2017 | |
| September 30, 2017 | 71.96% |
| June 30, 2017 | 73.01% |
| March 31, 2017 | 74.22% |
| December 31, 2016 | 73.59% |
| September 30, 2016 | 73.02% |
| June 30, 2016 | 72.89% |
| March 31, 2016 | 72.81% |
| Date | Value |
|---|---|
| December 31, 2015 | 74.16% |
| September 30, 2015 | 75.06% |
| June 30, 2015 | 75.53% |
| March 31, 2015 | 74.32% |
| December 31, 2014 | 75.53% |
| September 30, 2014 | 74.01% |
| June 30, 2014 | 75.90% |
| March 31, 2014 | 73.89% |
| December 31, 2013 | 76.13% |
| September 30, 2013 | 79.25% |
| June 30, 2013 | 80.35% |
| March 31, 2013 | 79.32% |
| December 31, 2012 | 79.05% |
| September 30, 2012 | 77.89% |
| June 30, 2012 | 79.53% |
| March 31, 2012 | 78.62% |
| December 31, 2011 | 78.14% |
| September 30, 2011 | 78.23% |
| June 30, 2011 | 80.36% |
| March 31, 2011 | 79.79% |
| December 31, 2010 | 80.08% |
| September 30, 2010 | 82.54% |
| June 30, 2010 | 82.19% |
| March 31, 2010 | 79.54% |
| December 31, 2009 | 75.88% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
71.02%
Minimum
Jun 2021
80.04%
Maximum
Jun 2019
76.52%
Average
77.64%
Median
Mar 2019
Gross Profit Margin (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | 88.28% |
| Amgen Inc | 74.98% |
| Johnson & Johnson | 67.57% |
| Merck & Co Inc | 66.17% |
| Pfizer Inc | 61.09% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 77.76% |
| Return on Assets | 12.85% |
| Return on Invested Capital | 24.81% |
| Profit Margin (Quarterly) | 24.36% |
| Operating Margin (Quarterly) | 32.91% |
| Return on Net Operating Assets | 17.51% |